May 3, 2025 - 01:43

China's recent advancements in counter-unmanned aerial vehicle (UAV) technology underscore not only significant technological progress but also the People's Liberation Army's (PLA) commitment to evolving its military strategies. These developments reflect a broader understanding of modern warfare, particularly in the context of emerging technologies and lessons learned from past conflicts.
The PLA's focus on counter-UAV capabilities signifies a strategic shift towards dominating the electromagnetic battlespace, an area increasingly vital in contemporary military operations. As drones become more prevalent in both civilian and military applications, the ability to effectively counter these aerial threats is crucial for maintaining operational superiority.
Moreover, China's efforts in this domain reveal a proactive approach to military innovation, emphasizing the importance of adapting to technological trends and battlefield realities. This dedication not only enhances the PLA's defensive and offensive capabilities but also positions China as a formidable player in the global military landscape, keen on securing its interests and influence.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...